The global network point-of-care glucose testing market size was valued at USD 1.42 billion in 2025 and is projected to grow from USD 1.47 billion in 2026 to USD 1.93 billion by 2034, exhibiting a CAGR of 3.5% during the forecast period (2026-2034). Rising prevalence of diabetes, increasing demand for rapid diagnostic solutions, and growing adoption of connected healthcare technologies are contributing to the market expansion.

Key Highlights

• Largest Region: North America
• Fastest Growing Region: Asia-Pacific
• Largest Segment by Product: Glucose Meters
• Fastest Growing Segment by Product: Consumables
• Largest Segment by End User: Hospitals
• Fastest Growing Segment by End User: Home Care Settings

Market Dynamics

Market Driver

The increasing incidence of diabetes worldwide is creating substantial demand for accurate and rapid glucose monitoring solutions. Healthcare providers are increasingly adopting network point-of-care glucose testing systems to improve patient management and enable timely clinical decision-making. The growing emphasis on connected healthcare infrastructure and digitalization is further supporting market growth.

Furthermore, advancements in wireless connectivity and data management technologies are enabling seamless integration of glucose monitoring systems with hospital information systems and electronic medical records. Such developments are enhancing workflow efficiency and improving patient outcomes, thereby driving market expansion.

Market Restraint

Despite technological advancements, the high cost associated with advanced network-enabled glucose testing devices and maintenance remains a challenge for widespread adoption, particularly in developing economies. Budget constraints in healthcare facilities can hinder investments in sophisticated diagnostic infrastructure.

In addition, concerns regarding data security, interoperability issues, and stringent regulatory requirements may slow the implementation of connected glucose testing systems. Compliance with healthcare standards and cybersecurity protocols presents additional challenges for manufacturers.

Market Opportunity

Growing demand for remote patient monitoring and home-based healthcare services is expected to create lucrative opportunities for market participants. Increasing awareness regarding diabetes management and the expansion of telehealth platforms are encouraging the adoption of connected glucose monitoring solutions.

Emerging economies across Asia-Pacific and Latin America are witnessing significant healthcare investments and improving medical infrastructure. These developments are expected to open new avenues for manufacturers and accelerate market penetration during the forecast period.

Top Market Players

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Danaher Corporation
• Nova Biomedical
• EKF Diagnostics Holdings plc
• Arkray Inc.
• Trividia Health Inc.
• ACON Laboratories Inc.
• Prodigy Diabetes Care LLC

Market Segmentation

By Product

• Glucose Meters
• Consumables

By End User

• Hospitals
• Clinics
• Home Care Settings
• Others

Regional Analysis

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/network-point-of-care-glucose-testing-market

Comprehensive analysis of market trends, growth opportunities, competitive landscape, regional outlook, and future developments are available in the complete report.

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights and market research reports.

Contact Us

Email: sales@straitsresearch.com

U.S.: +1 646 905 0080

U.K.: +44 203 695 0070